4//SEC Filing
Glickman Mark A 4
Accession 0001209191-22-021212
CIK 0000025743other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 7:00 AM ET
Size
5.7 KB
Accession
0001209191-22-021212
Insider Transaction Report
Form 4
Glickman Mark A
Chief Business Officer
Transactions
- Award
Restricted Stock Units
2022-03-23+260,000→ 260,000 totalExercise: $0.00→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001441461
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 7:00 AM ET
- Size
- 5.7 KB